Submitted by Anonymous (not verified) on 10 June 2026 - 14:50
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 29, Status: Authorised